UVE UNIVERSAL delivers 425 percent Q1 2026 EPS beat shares rise 314 percent on upbeat investor reaction AUR Aurora Q4 2025 EPS exceeds consensus forecasts shares post small gains during regular trading COFK Capital One leadership reaffirms preferred stock fixed income stability priorities in latest quarterly earnings update SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading MEDP Medpace Holdings shares rise 435 percent after Q1 2026 EPS outpaces consensus analyst expectations